FoxO4 inhibits atherosclerosis through its function in bone marrow derived cells

Atherosclerosis

Volumn 219, Issue 2, 2011, Pages 492-498

  Zhu, Min ^a,b   Zhang, Qing Jun ^a,b   Wang, Lin ^a,b   Li, Hao ^a,b   Liu, Zhi Ping ^a,b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Bone marrow; FoxO; Inflammation; Macrophage

Indexed keywords

APOLIPOPROTEIN E; FAT; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; REACTIVE OXYGEN METABOLITE; TRANSCRIPTION FACTOR FOXO; TRANSCRIPTION FACTOR FOXO4; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BONE MARROW CELL; BONE MARROW TRANSPLANTATION; CELL STIMULATION; CONTROLLED STUDY; DRUG MECHANISM; FEMALE; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; LIPID DIET; MALE; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; T LYMPHOCYTE; TRANSCRIPTION REGULATION; UPREGULATION;

ANIMALS; AORTIC DISEASES; APOLIPOPROTEINS E; ATHEROSCLEROSIS; BONE MARROW CELLS; BONE MARROW TRANSPLANTATION; CELLS, CULTURED; DIET, HIGH-FAT; DISEASE MODELS, ANIMAL; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; INFLAMMATION MEDIATORS; INTERLEUKIN-6; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; T-LYMPHOCYTES; TRANSFECTION; TRANSPLANTATION CHIMERA;

EID: 82955212994     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2011.09.038     Document Type: Article

References (43)

1. Lloyd-Jones D., Adams R., Carnethon M., et al. Heart disease and stroke statistics - 2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2009, 119:e21-e181.
2. Davidson M.H. Novel nonstatin strategies to lower low-density lipoprotein cholesterol. Curr Atheroscler Rep 2009, 11:67-70.
3. Klingenberg R., Hansson G.K. Treating inflammation in atherosclerotic cardiovascular disease: emerging therapies. Eur Heart J 2009, 30:2838-2844.
4. Sadowitz B., Maier K.G., Gahtan V. Basic science review: statin therapy - part I. The pleiotropic effects of statins in cardiovascular disease. Vasc Endovascular Surg 2010, 44:241-251.
5. Libby P., Okamoto Y., Rocha V.Z., et al. Inflammation in atherosclerosis: transition from theory to practice. Circ J 2010, 74:213-220.
6. Shin H.S., Lee H.J., Nishida M., et al. Betacellulin and amphiregulin induce upregulation of cyclin D1 and DNA synthesis activity through differential signaling pathways in vascular smooth muscle cells. Circ Res 2003, 93:302-310.
7. Raines E.W., Ferri N. Thematic review series: the immune system and atherogenesis. Cytokines affecting endothelial and smooth muscle cells in vascular disease. J Lipid Res 2005, 46:1081-1092.
8. Ronnebaum S.M., Patterson C. The FoxO family in cardiac function and dysfunction. Annu Rev Physiol 2010, 72:81-94.
9. van der Vos K.E., Coffer P.J. The extending network of FOXO transcriptional target genes. Antioxid Redox Signal 2011, 14:579-592.
10. Senokuchi T., Liang C.P., Seimon T.A., et al. Forkhead transcription factors (FoxOs) promote apoptosis of insulin-resistant macrophages during cholesterol-induced endoplasmic reticulum stress. Diabetes 2008, 57:2967-2976.
11. Keizer P.L., Burgering B.M., Dansen T.B. Forkhea d Box O as a sensor, mediator, and regulator of redox signaling. Antioxid Redox Signal 2011, 14:1093-1106.
12. Dejean A.S., Hedrick S.M., Kerdiles Y.M. Highly specialized role of Foxo transcription factors in the immune system. Antioxid Redox Signal 2011, 14:663-674.
13. Fabre S., Carrette F., Chen J., et al. FOXO1 regulates l-selectin and a network of human T cell homing molecules downstream of phosphatidylinositol 3-kinase. J Immunol 2008, 181:2980-2989.
14. Dengler H.S., Baracho G.V., Omori S.A., et al. Distinct functions for the transcription factor Foxo1 at various stages of B cell differentiation. Nat Immunol 2008, 9:1388-1398.
15. Liu Z.P., Wang Z., Yanagisawa H., et al. Phenotypic modulation of smooth muscle cells through interaction of Foxo4 and myocardin. Dev Cell 2005, 9:161-270.
16. Li H., Liang J., Castrillon D.H., et al. Foxo4 regulates TNFα-directed smooth muscle cell migration by activating matrix metalloproteinase 9 gene transcription. Mol Cell Biol 2007, 27:2676-2686. PMCID: PMC1899894.
17. Zhou W., Cao Q., Peng Y., et al. FoxO4 inhibits NF-κB and protects mice against colonic injury and inflammation. Gastroenterology 2009, 137:1403-1411.
18. Paik J.H., Kollipara R., Chu G., et al. FoxOs are lineage-restricted redundant tumor suppressors and regulate endothelial cell homeostasis. Cell 2007, 128:309-323.
19. Daugherty A., Rateri D.L. Development of experimental designs for atherosclerosis studies in mice. Methods 2005, 36:129-138.
20. Baglione J., Smith J.D. Quantitative assay for mouse atherosclerosis in the aortic root. Methods Mol Med 2006, 129:83-95.
21. Mori N., Shirakawa F., Shimizu H., et al. Transcriptional regulation of the human interleukin-6 gene promoter in human T-cell leukemia virus type I-infected T-cell lines: evidence for the involvement of NF-kappa B. Blood 1994, 84:2904-2911.
22. Nakashima Y., Plump A.S., Raines E.W., et al. ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. Arterioscler Thromb 1994, 14:133-140.
23. Lessner S.M., Prado H.L., Waller E.K., et al. Atherosclerotic lesions grow through recruitment and proliferation of circulating monocytes in a murine model. Am J Pathol 2002, 160:2145-2155.
24. Aparicio-Vergara M., Shiri-Sverdlov R., de Haan G., Hofker M.H. Bone marrow transplantation in mice as a tool for studying the role of hematopoietic cells in metabolic and cardiovascular diseases. Atherosclerosis 2010, 213:335-344.
25. Zhao H., Kalivendi S., Zhang H., et al. Superoxide reacts with hydroethidine but forms a fluorescent product that is distinctly different from ethidium: potential implications in intracellular fluorescence detection of superoxide. Free Radic Biol Med 2003, 34:1359-1368.
26. Chiribau C.B., Cheng L., Cucoranu I.C., et al. FOXO3A regulates peroxiredoxin III expression in human cardiac fibroblasts. J Biol Chem 2008, 283:8211-8217.
27. Harrison D., Griendling K.K., Landmesser U., et al. Role of oxidative stress in atherosclerosis. Am J Cardiol 2003, 91:7A-11A.
28. Souza H.P., Cardounel A.J., Zweier J.L. Mechanisms of free radical production in the vascular wall. Coron Artery Dis 2003, 14:101-107.
29. Park Y.M., Febbraio M., Silverstein R.L. CD36 modulates migration of mouse and human macrophages in response to oxidized LDL and may contribute to macrophage trapping in the arterial intima. J Clin Invest 2009, 119:136-145.
30. Tabas I. The role of endoplasmic reticulum stress in the progression of atherosclerosis. Circ Res 2010, 107:839-850.
31. Brasier A.R. The nuclear factor-kappaB-interleukin-6 signalling pathway mediating vascular inflammation. Cardiovasc Res 2010, 86:211-218.
32. Gareus R., Kotsaki E., Xanthoulea S., et al. Endothelial cell-specific NF-kappaB inhibition protects mice from atherosclerosis. Cell Metab 2008, 8:372-383.
33. Van der Heiden K., Cuhlmann S., Luong le A., et al. Role of nuclear factor kappaB in cardiovascular health and disease. Clin Sci (Lond) 2010, 118:593-605.
34. Ando H., Tsuruoka S., Yamamoto H., et al. Regulation of cholesterol 7alpha-hydroxylase mRNA expression in C57BL/6 mice fed an atherogenic diet. Atherosclerosis 2005, 178:265-269.
35. Nishina P.M., Verstuyft J., Paigen B. Synthetic low and high fat diets for the study of atherosclerosis in the mouse. J Lipid Res 1990, 31:859-869.
36. Traub O., Berk B.C. Laminar shear stress: mechanisms by which endothelial cells transduce an atheroprotective force. Arterioscler Thromb Vasc Biol 1998, 18:677-685.
37. Haidari M., Ali M., Gangehei L., et al. Increased oxidative stress in atherosclerosis-predisposed regions of the mouse aorta. Life Sci 2010, 87:100-110.
38. Hansson G.K., Jonasson L. The discovery of cellular immunity in the atherosclerotic plaque. Arterioscler Thromb Vasc Biol 2009, 29:1714-1717.
39. Andersson J., Libby P., Hansson G.K. Adaptive immunity and atherosclerosis. Clin Immunol 2010, 134:33-46.
40. Dienz O., Rincon M. The effects of IL-6 on CD4 T cell responses. Clin Immunol 2009, 130:27-33.
41. Kenyon C.J. The genetics of ageing. Nature 2010, 464:504-512.
42. Puig O., Tjian R. Nutrient availability and growth: regulation of insulin signaling by dFOXO/FOXO1. Cell Cycle 2006, 5:503-505.
43. Lee K.S., Iijima-Ando K., Iijima K., et al. JNK/FOXO-mediated neuronal expression of fly homologue of peroxiredoxin II reduces oxidative stress and extends life span. J Biol Chem 2009, 284:29454-29461.